A reduction-responsive amphiphilic core-shell micelle for miriplatin delivery was prepared and evaluated. A pyrene-terminated poly(2-(dimethylamino) ethyl acrylate) was synthesized through reversible addition–fragmentation chain transfer polymerization with 4-cyano-4-(ethylthiocarbonothioylthio) pentanoic acid as reversible addition–fragmentation chain transfer reagent and further modified by 2,2′-dithiodiethanol and 1-pyrenebutyric acid. Self-assembled blank micelles and drug-loaded micelles were obtained by dialysis method, and the particle size was proved to be about 40 nm with narrow dispersity by dynamic laser light scattering. Morphology results showed that blank micelles and drug-loaded micelles were spherical nanoparticles confirmed by transmission electron microscope, and the critical micelle concentration was as low as 6.09 µg/mL via pyrene fluorescence probe method. The reductive sensitivity of disulfide bond in BMs was further verified by changes in particle size, pyrene fluorescence intensity ratio (I338/I333), and morphology after treatment by dithiothreitol. Moreover, drug release rate in vitro of drug-loaded micelles was evaluated and the results suggested that this amphiphilic pyrene-modified poly(2-(dimethylamino) ethyl acrylate) can be used as reduction-triggered controlled release drug delivery carrier for hydrophobic drug.
DufourJ-FJohnsonP. Liver cancer: from molecular pathogenesis to new therapies: summary of the EASL single topic conference. J Hepatol2010; 52: 296–304.
2.
IshikawaTAbeSInoueRSuganoTWatanabeYIwanagaASekiKHonmaTNemotoTTakedaKYoshidaT. Predictive factor of local recurrence after balloon-occluded TACE with miriplatin (MPT) in hepatocellular carcinoma. PLoS One2014; 9: e 103009– e 103009.
3.
OkusakaTOkadaSNakanishiTFujiyamaSKuboY. Phase II trial of intra-arterial chemotherapy using a novel lipophilic platinum derivative (SM-11355) in patients with hepatocellular carcinoma. Invest New Drugs2004; 22: 169–76.
4.
OkusakaTKasugaiHIshiiHKudoMSataMTanakaKShioyamaYChayamaKKumadaHYoshikawaM. A randomized phase II trial of intra-arterial chemotherapy using SM-11355-(Miriplatin) for hepatocellular carcinoma. Invest New Drugs2012; 30: 2015–2025..
5.
IwazawaJOhueSHashimotoNMitaniT. Local tumor progression following lipiodol-based targeted chemoembolization of hepatocellular carcinoma: a retrospective comparison of miriplatin and epirubicin. Cancer Manage Res2012; 4: 113–9.
6.
MiyayamaSYamashiroMShibataYHashimotoMYoshidaMTsujiKToshimaFMatsuiO. Comparison of local control effects of superselective transcatheter arterial chemoembolization using epirubicin plus mitomycin C and miriplatin for hepatocellular carcinoma. Jpn J Radiol2012; 30: 263–70.
7.
HanadaMBabaATsutsumishitaYNoguchiTYamaokaT. Intra-hepatic arterial administration with miriplatin suspended in an oily lymphographic agent inhibits the growth of human hepatoma cells orthotopically implanted in nude rats. Cancer Sci2009; 100: 189–94.
8.
HanadaMBabaATsutsumishitaYNoguchiTYamaokaTChibaNNishikakuF. Intra-hepatic arterial administration with miriplatin suspended in an oily lymphographic agent inhibits the growth of tumors implanted in rat livers by inducing platinum-DNA adducts to form and massive apoptosis. Cancer Chemother Pharmacol2009; 64: 473–83.
9.
OguroSHashimotoSTanakaTInoueMNakatsukaSKuribayashiSAsakuraKKawachiSTanabeMKitagawaY. Short-term therapeutic effects of transcatheter arterial chemoembolization using miriplatin-lipiodol suspension for hepatocellular carcinoma. Jpn J Radiol2012; 30: 735–42.
10.
OkabeKBeppuTHaraokaKOh-UchidaYYamamuraSTomiyasuSYamanakaTSanoOMasudaTChikamotoA. Safety and short-term therapeutic effects of miriplatin-lipiodol suspension in transarterial chemoembolization (TACE) for hepatocellular carcinoma. Anticancer Res2011; 31: 2983–8.
11.
FacciorussoALicinioRMuscatielloNAlfredoDLBaroneM. Transarterial chemoembolization: evidence from the literature and applications in hepatocellular carcinoma patients. World J Hepatol2015; 7: 2009–2019.
12.
KouichiSMasayukiY. Polymeric micelles possessing polyethyleneglycol as outer shell and their unique behaviors in accelerated blood clearance phenomenon. Bio Pharm Bull2013; 36: 878–82.
13.
HuangPWangWZhouJZhaoFZhangYLiuJLiuJDongAKongDZhangJ. Amphiphilic polylectrolyte/prodrug nanoparticles constructed by synergetic electrostatic and hydrophobic interactions with cooperate pH-sensitivity for controlled doxorubicin delivery. ACS Appl Mater Interfaces2015; 7: 6340–50.
14.
Ruiyuan L, Yan L, Zhenzhong Z, Xin Z. Drug carriers based on highly protein-resistant materials for prolonged in vivo circulation time. Regen Biomater 2015;2:125–33.
LipingAYapeiWXiaomeiLNingMHaiyingDuMinghuaJYingLLongZYanlingXPeiliHZhiweiS. Block ionomer complex micelles based on the self-assembly of poly(ethylene glycol)-block-poly(acrylic acid) and CdCl2 for anti-tumor drug delivery. Chem Pharm Bull2011; 59: 559–63.
17.
MaedaHGreishKFangJ. The EPR effect and polymeric drugs: a paradigm shift for cancer chemotherapy in the 21st century. Adv Polym Sci2006; 193: 103–121.
18.
LianXMWuDXSongXHZhaoHY. Synthesis and self-assembly of amphiphilic asymmetric macromolecular brushes. Macromolecules2010; 43: 7434–45.
19.
LiuJXLiuZLuoXZongXDLiuJQ. RAFT controlled synthesis of biodegradable polymer brushes on graphene for DNA binding and release. Macromolecular2013; 214: 2266–75.
20.
Vazquez-DorbattVLeeJLinEWMaynardHD. Synthesis of glycopolymers by controlled radical polymerization techniques and their applications. Chembiochem2012; 13: 2478–87.
21.
WangWZhangJLiCHuangPGaoSHanSDongAKongD. Facile access to cytocompatible multicompartment micelles with adjustable janus-cores from A-block-B-graft-C terpolymers prepared by combination of ROP and ATRP. Colloids Surf B Biointerfaces2014; 115: 302–9.
22.
WangWLiCZhangJDongAKongD. Tailor-made gemcitabine prodrug nanoparticles from well-defined drug-polymer amphiphiles prepared by controlled living radical polymerization for cancer chemotherapy. J Mater Chem B2014; 3: 1891–1901.
23.
MatyjaszewskiKXiaJH. Atom transfer radical polymerization. Chem Rev2001; 101: 2921–90.
24.
TaoLLiuJQTanBHDavisTP. RAFT synthesis and DNA binding of biodegradable, hyperbranched poly(2-(dimethylamino)ethyl) methacrylate. Macromolecules2009; 42: 4960–2.
25.
YeTAleksandraGWenZThomasKMalcolmX. Polymeric mesoporous silica nanoparticles as a pH-responsive switch to control doxorubicin intracellular delivery. J Mater Chem B2013; 1: 5264–72.
26.
HartonoSBPhuocNTYuMHJiaZFMonteiroMJQiaoSHYuCZ. Functionalized large pore mesoporous silica nanoparticles for gene delivery featuring controlled release and co-delivery. J Mater Chem B2014; 2: 718–26.
27.
TaoLLiuJQDavisTP. Branched polymer-protein conjugates made from mid-chain-functional p(HPMA). Biomacromolecules2009; 10: 2847–51.
QianCYongSJiangjunWGuowenYZhaoyuanCHongliYHaitianW. Preparation and characterization of glycyrrhetinic acid-modified stearic acid-grafted chitosan micelles*. Artif Cells Nanomed Biotechnol2013; 43: 217–23.
30.
LeeKYKwonICKimYHJoWHJeongSY. Preparation of chitosan self-aggregates as a gene delivery system. J Control Release1998; 51: 213–20.
31.
PanYJChenYYWangDRWeiCGuoJLuDRChuCCWangCC. Redox/pH dual stimuli-responsive biodegradable nanohydrogels with varying responses to dithiothreitol and glutathione for controlled drug release. Biomaterials2012; 33: 6570–9.
32.
HostetterAAOsbornMFDeRoseVJ. RNA-Pt adducts following cisplatin treatment of saccharomyces cerevisiae. ACS Chem Biol2012; 7: 218–25.
